In humans, about 50 ABC proteins play physiologically important roles. Many ABC proteins are involved in lipid outward translocation and lipid homeostasis in the body and defects in their functions causes various diseases; however, the precise mechanisms of substrate transport remain unclear. In bacteria, several ABC proteins are involved in the transport of lipoproteins and lipopolysaccharides from the inner to outer membrane, and their functions are prerequisite for their survival. Their functions can be divided into "flip-flop" and "projection". In this review, human ABC proteins are compared to bacterial proteins to elucidate their mechanisms. 
Introduction
The lipid bilayer is the ideal barrier for life to maintain concentrations of solutes in cytosol and selectively segregate biochemical reactions from the external environment. Because water-soluble molecules and inorganic ions hardly dissolve in lipid bilayers or diffuse across them, specific membrane proteins, transporters and channels, which transport water-soluble molecules and inorganic ions across lipid bilayers, have evolved and cells have achieved competency to ingest essential nutrients, excrete metabolic waste products, and regulate intracellular ion concentrations. By contrast, because hydrophobic molecules readily dissolve in lipid bilayers and diffuse across them, they have been considered to move according to their concentration gradient across membranes in cells and in the body.
We identified human MDR1 gene (now called ABCB1 by the HUGO (Human Gene Organization) Nomenclature Committee) amplified and overexpressed in multidrug-resistant carcinoma cell lines in 1986 [1, 2] , and showed that it confers multidrug resistance depending on its own expression. Afterwards, ABCB1 turned out to code for P-glycoprotein [3] , a surface glycoprotein overexpressed in drug-resistant Chinese hamster ovary cell mutants [4] . MDR1 extrudes a very wide array of structurally dissimilar compounds, all lipophilic or amphiphilic, and ranging in mass from approximately 300 to 2000 Da, including cytotoxic drugs that act on different intracellular targets [5] [6] [7] . MDR1 is clinically important because it not only confers multidrug resistance to cancer cells but also affects the pharmacokinetics of various drugs [8, 9] . This discovery suggested that lipophilic endogenous compounds, which have been considered to 3 move according to their concentration gradient in cells and in the body, could be also actively transported across membranes in an ATP-dependent manner. Indeed, it was revealed in 1993 that murine ABCB4 (also called MDR2), highly homologous to MDR1, is involved in phosphatidylcholine (PC) transport and is indispensable for bile formation [10] .
Although several mechanisms have been proposed for substrate recognition and transport by MDR1 and other ABC proteins [11] [12] [13] [14] , they remain to be clarified. Four processes can be predicted for outward lipid transport across membranes, as seeing in Fig. 1. (a) The substrates enter the transporter from the inner leaflet and exit from the transporter into the outer leaflet.
Substrates could be moved from one substrate binding site to the other in the transporter in a In this review, the mechanism of outward transmembrane lipid transport by physiologically important human ABC proteins will be discussed. First, ABC proteins involved in the biogenesis of the outer membrane in Gram-negative bacteria are described. Their transport mechanisms have been studied intensively and are highly suggestive when considering the mechanism of human ABC proteins.
Bacterial ABC proteins in lipoprotein transport
The outer membrane is essential for Gram-negative bacteria, such as Eschericia coli (E. coli). One of the major functions of the outer membrane is a permeability barrier to hydrophobic substances. It is composed of four major components: lipopolysaccharide (LPS), phospholipids, -barrel proteins, and lipoproteins. E. coli possesses at least 80 species of lipoproteins anchored to the periplasmic face of the outer membrane thorough acyl chains attached to their N-terminal Cys residues. Lipoproteins are synthesized as precursors in the cytoplasm, and translocated across the inner membrane through a Sec translocon. The precursor proteins are then sequentially processed to the mature acylated form on the periplasmic face of the inner membrane. Because the signal peptide is processed by a signal peptidase, the mature lipoproteins are anchored via only three acyl chains (Fig. 2a) .
Extensive biochemical studies by Tokuda's group [15] [16, 17] . Thus, the outward transport process mediated by LolCDE represents the model (d) in Fig. 1 , in which the substrate is "projected" from the outer leaflet of the membrane.
Bacterial ABC proteins in LPS transport
LPS is an essential component of the outer membrane in most Gram-negative bacteria as lipoproteins. LPS consists of a hydrophobic membrane anchor, lipid A moiety, linked to a short core oligosaccharide and a distal long chain polysaccharide known as O-antigen. The lipid A-core moiety is synthesized on the cytoplasmic surface of the inner membrane and is then 6 transported across the inner membrane by an ABC transporter, MsbA. The movement of the lipid A-core moiety mediated by MsbA is "flip-flop" from the inner leaflet to the outer leaflet of the inner membrane [18] . Thus, the outward transport process mediated by MsbA represents the model (a) in Fig. 1 . O-antigen is synthesized separately and is present in its completed form at the periplasmic face of the inner membrane, attached to the carrier lipid (undecaprenyl diphosphate). O-antigen repeat units are then polymerized in the periplasm and ligated to the lipid A-core moiety [19] .
Recently, several proteins have been identified to be involved in LPS transport from the inner to outer membrane of E. coli [20, 21] . Two transmembrane proteins, LptF and LptG, form a complex with LptB, a cytosolic ATPase, with a subunit stoichiometry of 1:1:2, just like LolCDE [22] . LPS is predicted to target the outer membrane through a pathway analogous to the lipoprotein targeting system. LptA may play a chaperone role in the transport of LPS across the periplasm (Fig. 2b ).
It is intriguing that two types of outward transporter are involved in LPS transport from the inner to outer membrane. One is MsbA, which moves lipid A-core moiety in a "flip-flop" manner as does model (a), and the other is LptBFG, which possibly "projects" mature LPS to
LptA, just like LolCDE as in model (d). There may be two possible reasons why two separate systems are required for bacteria to transport LPS: i) the two transport steps are separated because polymerized O-antigen should be ligated to the lipid A-core moiety on the periplasmic face of the inner membrane after being transported by MsbA and then recognized by LptBFG. ii) The other reason might be that the two processes, "flip-flop" and "projection", cannot be mediated by one bacterial ABC transporter but need to be shared by two ABC transporter systems.
Human ABC proteins in xenobiotic transport
In daily life, we are exposed to various hydrophobic compounds in food and the environment that are apt to pass through the lipid bilayer freely and penetrate our body;
inconveniently, many of them have toxic effects. Therefore, our body has to deal with numerous hydrophobic compounds in food and the environment; however, it is impossible to cover the intestine epithelia with cell walls, like bacteria as described in the previous chapters, or to express a huge number of membrane transporters which excrete each hydrophobic toxic compound with high efficiency. Animals have developed mainly two strategies to cope with these hydrophobic substances. One strategy is that hydrophobic toxic substances are conjugated with glutathione, glucuronate, or sulfate, whereby they become more hydrophilic and detoxified. At the same time, these markings make toxic compounds much easier to recognize by transporters. Several ABCC subfamily proteins (MRPs) are involved in transporting these marked compounds out of cells [23] [24] [25] [26] [27] . The marked substrates, being hydrophilic, probably directly enter the transporter from cytosol and exit directly to an exogenous environment, as in model (c) in Fig. 1 . This pathway is very efficient but has an intrinsic defect, because toxic substances need to be taken into cells to be marked.
The other strategy is to recognize numerous hydrophobic compounds while passing through 8 the plasma membrane and to excrete them directly out of cells. This is accomplished mainly by two ABC proteins MDR1 and ABCG2 [9, 28] . They prevent the absorption of lipophilic toxic compounds of various structures from the intestine, and expels them to bile and urine from the liver and kidney, respectively, although their binding affinities are rather low and in the micromolar range.
The substrates are predicted to enter the transporter from the membrane. Calcein-AM, added to the medium, is efficiently excreted by MDR1 out of cells before being hydrolyzed by esterases in cytosol [29] . Because calcein, the hydrolyzed product, is not the substrate for MDR1, calcein-AM must be recognized while passing through the membrane by MDR1. It is not clear whether substrates exit the transporter to the outer leaflet, as in model (a) in Fig. 1 , or directly to an exogenous environment as in model (b); however, because lipophilic compounds readily diffuse inwardly again, it may be necessary to expel them directly to some acceptors, such as albumin, in an exogenous environment for efficient outward transport, as in model (b).
ABCB4 in PC transport
Bile formation is important for cholesterol excretion from the body as well as cholesterol absorption from the intestine, and thus it is critical for overall cholesterol homeostasis. Several ABC proteins, expressed on the apical membranes of hepatocytes, are involved in the secretion of bile salts, phospholipids and cholesterol, and thus in canalicular bile formation. ABCB4, also called MDR3 in humans or MDR2 in mice, is essential for the secretion of phosphatidylcholine (PC) into bile [10] . ABCB11, also called a bile salt export pump or a sister of P-glycoprotein, secretes bile salts into bile [30] . ABCG5 and ABCG8 are the main transporters for the secretion of biliary cholesterol [31] .
The function of ABCB4 is required for proper bile formation. Mice with homozygous disruption of the Abcb4 gene show an almost complete absence of PC in their bile [10] , which causes segmental biliary strictures due to periductal fibrosis, fibro-obliteration of bile ducts, and spontaneous gallstone formation. Human ABCB4 mutations result in a wide spectrum of phenotypes, ranging from progressive familial intrahepatic cholestasis type 3 to adult cholestatic liver disorders, characterized by elevated -glutamyl transpeptidase levels. The primary function of biliary phospholipid excretion is to protect the membranes of cells facing the biliary tree against bile salts via forming mixed micelles [32] .
ABCB4 has an amino acid sequence with 76% identity and 86% similarity to that of MDR1, although ABCB4 does not confer drug resistance. Abcb4 knockout mice do not excrete any phospholipid into bile, despite the high expression of MDR1 on the canalicular membranes of hepatocytes. MDR1 has quite low, if any, ability to mediate phospholipid excretion, although it actively transports an enormously broad range of compounds to bile. ABCB4 is predicted to transport PC from the inner to the outer leaflet of the canalicular membrane in the "flip-flop" manner, as in model (a) in Fig. 1 and to make PC available for extraction into the canalicular lumen by bile salts [33] [34] [35] . ABCB4 exclusively translocates a fluorescent short-chain PC analog containing a 7-nitro-2,1,3-benzoxadiazol group (C 6 -NBD-PC) [34] . Interestingly, MDR1
translocates not only C 6 -NBD-PC but also C 6 -NBD-PE [34] . It has been reported that both MDR1 and ABCB4 confer resistance to aureobasidin A, an antifungal cyclic depsipeptide antibiotic, when expressed in yeast [36] . The resistance of yeast cells to aureobasidin A conferred by ABCB4 can be overcome by vinblastine, verapamil, and cyclosporin A.
Furthermore, human ABCB4 expressed in LLC-PK1 cells mediated transepithelial transport of C 6 -NBD-PC, digoxin, paclitaxel, daunorubicin, vinblastine, and ivermectin, although the transport rate is low for most drugs, and the transport is also inhibited by vinblastine, verapamil, and cyclosporin A [37] ; therefore, it is conceivable that MDR1 and ABCB4 share conserved domains for substrate recognition and a conserved process to transport substrates, although their physiological roles are quite different.
We reported that HEK293 cells stably expressing human ABCB4 excrete phospholipids (preferentially PC) and cholesterol when bile salts are added to the medium [38] . Because MDR1 or the ATPase-deficient mutant of ABCB4 did not mediate lipid excretion, and no lipid release was observed from host cells even in the presence of bile salts, excretion of PC and cholesterol is directly mediated by ABCB4 in an ATP-dependent manner. Abcg5/g8 -/-mice have ~80% reduced biliary cholesterol excretion [39] . Because more than 20% of biliary cholesterol excretion was still observed, ABCB4 might also contribute to the secretion of biliary cholesterol in some degree. Sodium taurocholate (NaTC) below the cmc promotes ABCB4-mediated lipid efflux, suggesting that bile salt monomers support lipid efflux. The crystal structure of sav1866, a bacterial homolog of ABCB1, has been reported [40] . The predicted outward-facing conformation contains a central cavity that is shielded from the inner leaflet of the lipid bilayer 11 and from the cytoplasm, but exposed to the outer leaflet and the extracellular space. Bile salt monomers may associate with phospholipid and cholesterol in the cavity of ABCB4, and then induce the formation of a mixed bile salt/phospholipid/cholesterol micelle, which is released into the extracellular space. The association of bile salt monomers with phospholipid and cholesterol would reduce the activation energy required to move substrates from the cavity of ABCB4 to the aqueous environment; therefore, PC, entering from the membrane, may exit directly to an exogenous environment as in model (b), as proposed for MDR1 in the previous chapter.
ABCA1 in HDL formation
Cholesterol is a key component of the cell membrane and is required for cell proliferation;
however, excess accumulation of cholesterol is toxic for cells and its excess deposition in peripheral tissues causes arteriosclerosis. Excess cholesterol is transported to the liver, where it is catabolized to bile acids, as high density lipoprotein (HDL) known as good cholesterol.
Because cholesterol is not catabolized in peripheral tissues, HDL formation is the only pathway by which excess cholesterol is removed from peripheral cells. At least 50 mutations, including 23 missense, and 21 insertions or deletions, have been identified in the ABCA1 gene, leading to
Tangier disease and familial hypoalphalipoproteinemia, in which patients have a near absence or decrease of circulating HDL, prominent cholesterol-ester accumulation in tissue macrophages, and premature atherosclerotic vascular disease [41] [42] [43] [44] [45] . More than 15 mutations examined showed a high correlation between phospholipids, preferentially PC, and cholesterol efflux [46] [47] [48] , indicating that ABCA1 influences the efflux of both PC and free cholesterol. ABCA1
mediates the secretion of both types of lipids to an extracellular acceptor in the plasma, apolipoprotein A-I (apoA-I), to form HDL [48, 49] , and the activity of ABCA1 is highly regulated at the transcriptional level and also at the post-translational level [50] [51] [52] [53] [54] [55] [56] .
Models for ABCA1-mediated HDL formation
Several models have been proposed for the mechanism of ABCA1-mediated HDL formation:
i) A two-step process model: ABCA1 first mediates PC efflux to apoA-I, and this apoA-I-PC complex accepts cholesterol in an ABCA1-independent manner; ii) a concurrent process model:
PC and cholesterol efflux by ABCA1 to apoA-I are coupled to each other; and iii) the third model is that ABCA1 generates a specific apoA-I binding site on the plasma membrane and subsequent translocation of PC and cholesterol to apoA-I. When it was proposed by Fielding, P. E. et al.
[57] and Wang, N. et al. [58] , the two-step model looked most plausible, because photoactive PC could be cross-linked with ABCA1 whereas direct binding of photoactive cholesterol to ABCA1
could not be detected [58] . However, analysis of functions of ABCA7 raised questions about this model. Human ABCA7, which has the highest homology (66.1%) to ABCA1, mediates the apoA-I-dependent efflux of PC and cholesterol, just as ABCA1 [59] ; however, human ABCA7 mediates cholesterol release much less efficiently than ABCA1 [60] , and PC but not cholesterol are loaded onto apoA-I by mouse ABCA7 [61] . These results cannot be explained by the two-step process model. Instead, they suggest that ABCA1 have higher affinity for cholesterol to transport than ABCA7 does, and are consistent with the concurrent process model [62] .
The third model was originally proposed by Chimini et al. [63] : ABCA1 mediates the 
Four-step model for ABCA1-mediated HDL formation
Mass and TLC analyses revealed that ABCG1 and ABCA1 secrete several species of sphingomyelin (SM) and PC, and SMs were preferentially secreted by ABCG1, whereas PCs were preferentially secreted by ABCA1 [65] . Thus, ABCA1 and ABCB4 mediate the transport of the same substrates, cholesterol and PC, but their extracellular acceptors are different.
ABCB4 mediates the secretion of PC and cholesterol to bile salts as acceptors, but cannot secrete lipids in the presence of apoA-I. On the other hand, cholesterol secretion by ABCA1 is strongly dependent on the presence of lipid-free apoA-I [66, 67] . ABCA1 and other members of the ABCA subclass are distinguished from other ABC transporter subclasses by the presence of large extracellular domains (ECDs) [68, 69] (Fig. 3) . Hozoji et al. revealed that two intramolecular disulfide bonds are formed between ECD1 and ECD2 of ABCA1, and these two disulfide bonds are necessary for apoA-I binding and HDL formation [70] . Direct interaction between ABCA1
and apoA-I has been shown via cross-linking experiments [46, 66, 67, 71] , even with a cross-linker 14 as small as 3 Å [72] . These results indicated that the direct binding of apoA-I to ABCA1 is an essential step in HDL formation.
To analyze the differences between ABCA1 and ABCB4, we examined whether NaTC serves as an acceptor for lipids secreted by ABCA1, and surprisingly found that NaTC extracts both cholesterol and PC as efficiently as apoA-I from cells expressing ABCA1 [73] . NaTC did not extract lipids from HEK293 host cells, suggesting that NaTC functions as a lipid acceptor for ABCA1, which mimics apoA-I. The NaTC-dependent efflux of cholesterol and PC is not physiologically relevant, because it is unlikely that the plasma concentration of bile acids reaches 1 mM; however, this system allowed us to analyze the role of apoA-I and dissect the steps in HDL formation.
Because apoA-I does not bind to cells expressing ABCA1-MM, a mutant in which the Walker A lysines in both nucleotide binding domains are substituted by methionines, apoA-I binding is an ATP-dependent process [73, 74] . The Tangier mutation W590S, one amino acid substitution in the first ECD, impairs HDL formation [46, 48] . We analyzed the function of this Tangier mutant in detail, and found that this mutation greatly decreases NaTC-dependent cholesterol and PC efflux [73] . ABCA1-W590S interacts in a normal manner with ATP [48] .
The W590S mutation may abolish the coupling of ATP-induced conformational changes of ABCA1 to lipid translocation. Interestingly, the kinetics of apoA-I binding to cells expressing ABCA1-W590S were similar to those for cells expressing wild-type ABCA1 [73] , consistent with a previous report showing that the W590S mutation does not impair apoA-I binding 15 [46, 47, 71, 75] ; however, the W590S mutation delayed the dissociation of apoA-I from ABCA1 [73] .
From these results, we propose that HDL formation mediated by ABCA1 consists of at least four separate steps (Fig. 3) : apoA-I binding step, ATP binding and/or hydrolysis causes conformational changes within ECDs of ABCA1, to which apoA-I directly binds; translocation step, lipid translocation by ABCA1, which is apoA-I-independent; loading step, lipid loading of apoA-I bound to ABCA1; and dissociation step, dissociation of lipid-loaded apoA-I from ABCA1. In this model, the apoA-I binding step and lipid translocation step, both of which are mediated by ABCA1 in an ATP-dependent manner, are separable. The conformational transition of apoA-I caused by lipid loading probably facilitates the dissociation of apoA-I from ABCA1.
ApoA-I undergoes a conformational transition in response to lipid [76] , and lipidated apoA-I does not interact with ABCA1 [66, 77] . Because the W590S mutation impairs translocation step, apoA-I may remain in lipid-free conformation, which has high affinity to ABCA1.
Flip-flop, efflux, or projection
As described in the previous chapter, both ABCA1 and ABCB4 mediate the efflux of PC and cholesterol to NaTC as a lipid acceptor in an ATP-dependent manner; therefore, it is conceivable to predict that they share conserved domains for substrate recognition and conserved process to transport substrates. PC and cholesterol, entering from the membrane, may exit directly to an exogenous environment as in model (b), as proposed for MDR1 and ABCB4.
ABCG1, half-type ABC proteins, functions as a homodimer and transports cholesterol to 16 nascent HDL to generate mature HDL. ABCG1 mediates the efflux of cholesterol and phospholipids, preferentially SM [65] . The ABCG1-mediated efflux of cholesterol and SM is dependent on the cellular SM level, because lipid efflux by ABCG1 was reduced in a mutant CHO-K1 cell line, LY-A, in which the cellular sphingomyelin level is reduced due to a mutation of ceramide transfer protein CERT [78] . In contrast, the ABCA1-mediated efflux of cholesterol and PC is enhanced in LY-A cells [79] . These results indicate that the substrate specificity of ABCA1 and ABCG1 is different; ABCA1 prefers PC and ABCG1 prefers sphingomyelin.
Alternatively, it is possible that ABCA1 preferentially functions in non-raft domains, which contain more PC than SM, and ABCG1 preferentially functions in raft domains, where SM is concentrated, in the plasma membrane.
As SM is synthesized in the lumen of trans-Golgi, and transferred by vesicular transport, SM mainly exists in the outer leaflet. Substrate binding sites of ABCG1 could exist in the outer leaflet, and lipids could enter the binding site mainly from the outer leaflet of the plasma membrane. If this is the case, the outward transport process mediated by ABCG1 would follow model (d) in Fig. 1 , in which the substrate is "projected" from the outer leaflet of the membrane without transmembrane movement, as LolCDE. PC also preferentially exists in the outer leaflet of the plasma membrane. Does this suggest that the outward transport process mediated by ABCA1 follows the model (d), as predicted for LolCDE? The four-step model for HDL formation mediated by ABCA1 and apoA-I (Fig. 3) looks similar to the model for the release of the lipoprotein from the inner membrane mediated by LolCDE and LolA (Fig. 2c) . Both apoA-I and LolA directly bind to ABCA1 and LolCDE, respectively. Both ABCA1 and 
